Provides for the disbursement of monies received in settlements from opioid manufacturers (OR SEE FISC NOTE SD EX)
Impact
The enactment of HB 389 will likely have significant implications for state policies related to public health and safety. By earmarking a portion of the settlement funds for educational programs, the bill aims to enhance awareness around addiction and overdose prevention, particularly in educational institutions. Furthermore, the allocation of funds to rehabilitation and treatment services demonstrates a commitment to provide resources for recovery efforts and support law enforcement in their operations against the opioid epidemic.
Summary
House Bill 389 establishes the Louisiana Opioid Settlement Fund, aimed at managing and utilizing funds received from opioid manufacturer settlements. This fund is intended to support educational programs, rehabilitation services, and addiction research, thereby addressing the ongoing opioid crisis in the state. The University of Louisiana at Monroe (ULM) is designated as the fund administrator, responsible for distributing the funds according to specific allocation guidelines. Notably, 20% of the fund will be dedicated to prevention efforts, 50% to crisis response, and 30% to research and development of non-addictive alternatives.
Sentiment
Overall, the sentiment around HB 389 appears to be largely positive, particularly among health advocates and educational institutions eager to see improved resources and awareness campaigns. However, there remains a level of skepticism about the effectiveness of these measures and whether the allocated funds will genuinely lead to substantial improvements in addressing addiction. Stakeholders are optimistic about the research components of the bill, hoping to facilitate innovations in pain management and addiction treatment.
Contention
One notable point of contention surrounding HB 389 is the challenge of ensuring that the funds are adequately allocated and managed by ULM. Stakeholders are concerned about potential bureaucratic inefficiencies that may hinder the swift deployment of resources to areas in urgent need. Additionally, there may be debates on whether the current allocation percentages appropriately reflect the most critical areas of need in combating addiction and supporting recovery efforts. The effectiveness of this fund in yielding tangible results remains a key consideration as the state grapples with the implications of the opioid crisis.
A bill for an act relating to the opioid settlement fund, making appropriations and disbursements, and including effective date and retroactive applicability provisions. (Formerly HSB 331.) Effective date: 06/06/2025, 07/01/2025. Applicability date: 07/01/2024.
Provides for funds received from opioid litigation or settlements to be dedicated for use in financing substance use disorder prevention and treatment programs and services in New Jersey.
Constitutional amendment to provide that once the balance in the Millennium Trust reaches $1.38 billion, 100% of the annual Tobacco Settlement Proceeds shall be dedicated to Health Excellence Fund initiatives. (2/3 - CA13s1(A)) (OR SEE FISC NOTE GF EX See Note)
Provides that abandonment of interstate pipeline segments located wholly in Louisiana are considered intrastate pipelines and are handled under the regulations of the Louisiana Public Service Commission. (gov sig)
Provides that once the balance in the Millennium Trust reaches $1.38 billion, 100% of the annual Tobacco Settlement Proceeds shall be dedicated to Health Excellence Fund initiatives. (See Act) (OR SEE FISC NOTE GF EX See Note)